Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Neuromuscular Block in Laparoscopic Colorectal Surgery
NCT02580188Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Proportion of Intra-abdominal Pressure (IAP) Alarm > 15 mmHg. Started Mar 2015; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02580188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02580188.